HuR's role in gemcitabine efficacy: an exception or opportunity?

Brody JR, Gonye GE. HuR's role in gemcitabine efficacy: an exception or opportunity? Wiley Interdiscip Rev RNA. 2011 May; 2(3):435-44.

View in: PubMed

subject areas

Antimetabolites, Antineoplastic
Deoxycytidine
Deoxycytidine Kinase
Humans
Pancreatic Neoplasms
RNA Processing, Post-Transcriptional
RNA, Messenger
RNA, Neoplasm
Systems Biology
Translational Medical Research
Treatment Outcome

authors with profiles

Jonathan Brody

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement